Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines (Q40503815)

21 September 2017

Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines (English)

1 reference

21 September 2017

1 reference

1 reference

0 references

Aitor Nogales

1

0 references

Luis Martinez-Sobrido

object named as

Luis Martínez-Sobrido

7

0 references

Pablo R Murcia

5

object named as

Pablo R Murcia

1 reference

21 September 2017

Aitor Nogales

1

1 reference

21 September 2017

Kai Huang

2

1 reference

21 September 2017

Marta L DeDiego

4

1 reference

21 September 2017

Colin R Parrish

6

1 reference

21 September 2017

language of work or name

English

0 references

publication date

14 October 2016

1 reference

21 September 2017

1 reference

21 September 2017

500

1 reference

21 September 2017

1-10

1 reference

Prevalence of and exposure factors for seropositivity to H3N8 canine influenza virus in dogs with influenza-like illness in the United States

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Live attenuated versus inactivated influenza vaccine in infants and young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Positive selection on the H3 hemagglutinin gene of human influenza virus A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Transmission of equine influenza virus to dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Serologic evidence of pandemic (H1N1) 2009 infection in dogs, Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Equine and Canine Influenza H3N8 Viruses Show Minimal Biological Differences Despite Phylogenetic Divergence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Infection and pathogenesis of canine, equine, and human influenza viruses in canine tracheas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

The multifunctional NS1 protein of influenza A viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Microevolution of canine influenza virus in shelters and its molecular epidemiology in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Intrahost evolutionary dynamics of canine influenza virus in naive and partially immune dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Serologic prevalence of antibodies against canine influenza virus (H3N8) in dogs in a metropolitan animal shelter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive c

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Immunity to respiratory viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Efficacy of the canine influenza virus H3N8 vaccine to decrease severity of clinical disease after cochallenge with canine influenza virus and Streptococcus equi subsp. zooepidemicus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Generation of recombinant influenza virus from plasmid DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

THE ORIGINS OF NEW PANDEMIC VIRUSES: The Acquisition of New Host Ranges by Canine Parvovirus and Influenza A Viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Influenza virus reservoirs and intermediate hosts: dogs, horses, and new possibilities for influenza virus exposure of humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Evaluation of virus isolation, one-step real-time reverse transcription polymerase chain reaction assay, and two rapid influenza diagnostic tests for detecting canine Influenza A virus H3N8 shedding in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Toward a universal influenza virus vaccine: prospects and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Attenuation of equine influenza viruses through truncations of the NS1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Evidence of transmission and risk factors for influenza A virus in household dogs and their owners.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Transmission of avian influenza virus (H3N2) to dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Canine susceptibility to human influenza viruses (A/pdm 09H1N1, A/H3N2 and B).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Influenza virus evolution, host adaptation, and pandemic formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

Influenza virus infection in racing greyhounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.10.008

10.1016/J.VIROL.2016.10.008

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference